Von Willebrand Factor’s effects during COVID-19-associated coagulopathy does not appear unique to the virus, but rather to the presence of inflammation, as other conditions such as sepsis, DIC, cancer, and malaria also show marked effects on the von Willebrand Factor. This evidence concerns the gene VWF and cancer.